Medios AG (OTCMKTS:MEDOF) Sees Large Increase in Short Interest

Medios AG (OTCMKTS:MEDOF) was the target of a significant growth in short interest in April. As of April 30th, there was short interest totaling 3,361 shares, a growth of 545.1% from the April 15th total of 521 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.

Medios Price Performance

Medios stock remained flat at C$13.64 during midday trading on Tuesday. Medios has a twelve month low of C$13.64 and a twelve month high of C$13.64. The firm has a fifty day moving average price of C$13.64 and a two-hundred day moving average price of C$13.64.

Medios Company Profile

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic infusion preparations, antibody therapies, virostatic and antibiotic medications, parenteral nutrition solutions, and investigational medicinal products.